Cardinal Capital Management Inc (North Carolina)’s Jazz Pharmaceuticals JAZZ Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.49M | Buy |
13,997
+743
| +6% | +$78.8K | 0.22% | 111 |
|
|
2025
Q1 | $1.65M | Buy |
13,254
+114
| +0.9% | +$14.2K | 0.25% | 103 |
|
|
2024
Q4 | $1.62M | Buy |
13,140
+641
| +5% | +$78.9K | 0.25% | 104 |
|
|
2024
Q3 | $1.39M | Buy |
12,499
+431
| +4% | +$48K | 0.22% | 113 |
|
|
2024
Q2 | $1.29M | Buy |
12,068
+227
| +2% | +$24.2K | 0.22% | 109 |
|
|
2024
Q1 | $1.43M | Buy |
11,841
+1,611
| +16% | +$194K | 0.23% | 105 |
|
|
2023
Q4 | $1.26M | Buy |
10,230
+246
| +2% | +$30.3K | 0.24% | 103 |
|
|
2023
Q3 | $1.29M | Buy |
9,984
+315
| +3% | +$40.8K | 0.26% | 92 |
|
|
2023
Q2 | $1.2M | Buy |
9,669
+45
| +0.5% | +$5.58K | 0.24% | 99 |
|
|
2023
Q1 | $1.41M | Sell |
9,624
-66
| -0.7% | -$9.66K | 0.29% | 95 |
|
|
2022
Q4 | $1.54M | Buy |
9,690
+34
| +0.4% | +$5.42K | 0.33% | 89 |
|
|
2022
Q3 | $1.29M | Sell |
9,656
-97
| -1% | -$12.9K | 0.3% | 93 |
|
|
2022
Q2 | $1.52M | Buy |
9,753
+217
| +2% | +$33.9K | 0.35% | 84 |
|
|
2022
Q1 | $1.48M | Buy |
9,536
+404
| +4% | +$62.9K | 0.3% | 90 |
|
|
2021
Q4 | $1.16M | Buy |
9,132
+156
| +2% | +$19.9K | 0.23% | 102 |
|
|
2021
Q3 | $1.17M | Buy |
8,976
+249
| +3% | +$32.4K | 0.25% | 98 |
|
|
2021
Q2 | $1.55M | Buy |
8,727
+2,731
| +46% | +$485K | 0.33% | 91 |
|
|
2021
Q1 | $986K | Buy |
5,996
+115
| +2% | +$18.9K | 0.22% | 110 |
|
|
2020
Q4 | $971K | Buy |
5,881
+375
| +7% | +$61.9K | 0.23% | 104 |
|
|
2020
Q3 | $785K | Buy |
5,506
+1,061
| +24% | +$151K | 0.22% | 98 |
|
|
2020
Q2 | $490K | Buy |
4,445
+2
| +0% | +$220 | 0.14% | 120 |
|
|
2020
Q1 | $443K | Buy |
+4,443
| New | +$443K | 0.15% | 120 |
|